Аллергические болезни: диагностика и лечение - Паттерсон Р.
ISBN 5-9231-0011-8
Скачать (прямая ссылка):
65. Grammer L.C. et al. IgE against ethylene oxide-altered human serum albumin in patients with anaphylactic reactions to dialysis // Ibid. - 1985. - Vol. 76. - P. 511.
66. Seggev J.S. et al. IgE mediated anaphylaxis due to a psyllium-containing drug // Ann. Allergy. -1984.-Vol. 53.-P. 325.
67. Rohr A.S., Pappano J.E. Prophylaxis against fluorescein-induced anaphylactoid reactions // J. Allergy Clin. Immunol. - 1992. - Vol. 90. - 407.
68. Hamstra R.D. et al. Intravenous iron dextran in clinical medicine // JAMA. - 1980. - Vol. 243. -P. 1726.
69. Dykewicz M.S. et al. Plasma histamine but not anaphylatoxin levels correlate with generalized urticaria from infusions of antilymphocyte monoclonal antibodies // J. Lab. Clin. Med. - 1992. -Vol. 120.-P. 290.
70. Dixon F.J. et al. Pathogenesis of serum sickness // Arch. Pathol. - 1968. - Vol. 61. - P. 18.
71. Bielory L. et al. Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure // Medicine. - 1988. - Vol. 67. - P. 40.
72. Davidson J.R. et al. Immunology of a serum sickness/vasculitis reaction secondary to streptokinase used for acute myocardial infarction // Clin. Exp. Rheumatol. - 1988. - Vol. 6. - P. 381.
73. ErffineyerJ.E. Serum sickness // Ann. Allergy. - 1986. - Vol. 56. - P. 105.
74. Platt R. et al. Serum sickness-like reactions to amoxicillin, cefaclor, cephalexin, and trimethoprim-sulfamethoxazole // J. Infect. Dis. - 1988. - Vol. 158. - P. 474.
75. Barnett E.V. et al. Serum sickness and plasmacytosis: clinical, immunologic, and hematologic analysis // Am. J. Med. - 1963. - Vol. 35. - P. 113.
76. Lawley TJ. et al. A prospective clinical and immunologic analysis of patients with serum sickness // N. Engl. J. Med. - 1984. - Vol. 31. - P. 1407.
77. Gilliland B.C. Drug-induced autoimmune and hematologic disorders // Immunol. Allergy Clin. North Am. - 1991.-Vol. 11.-P. 525.
78. Morrow J.D. et al. Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects I I Circulation. - 1953. - Vol. 8. - P. 829.
79. Ladd A.T. Procainamide-induced lupus erythematosus // N. Engl. J. Med. - 1962. - Vol. 267. -P. 1357.
80. Pistiner M. et al. Lupus erythematosus in the 1980’s: a survey of 570 patients // Semin. Arthritis Rheum. - 1991. - Vol. 21. - P. 55.
81. Steinberg A.D. et al. Systemic lupus erythematosus // Ann. Intern. Med. - 1991. - Vol. 115. — P. 548.
82. Lahita R. et al. Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide 11 N. Engl. J. Med. - 1979. - Vol. 301. - P. 1382.
83. Stec G.P. et al. Remission of procainamide-induced lupus erythematosus with N-acetylprocainamide therapy 11 Ann. Intern. Med. - 1979. - Vol. 90. - P. 799.
84. Blomgren S.E. et al. Antinuclear antibody induced by procainamide: a prospective study I I N. Engl. J. Med. - 1969. - Vol. 281. - P. 64.
85. Gleichmann E. et al. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological disease // Immunol. Today. - 1984. - Vol. 5. - P. 324.
415
86. Fauci A.S. Vasculitis 11 J. Allergy Clin. Immunol. - 1983. - Vol. 72. - P. 211.
87. Hunder G.G. et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis: introduction // Arthritis Rheum. - 1990. - Vol. 33. - P. 1065.
88. Arellano F., Sacristan J.A. Allopurinol hypersensitivity syndrome: a review // Ann. Pharmacother. - 1993. - Vol. 27. - P. 337.
89. Bigby M. et al. Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15 438 consecutive inpatients, 1975 to 1983 // JAMA. - 1986. -Vol. 256. - P. 3358.
90. Kauppinen K. Rational performance of drug challenge in cutaneous hypersensitivity // Semin. Dermatol. - 1983. - Vol. 2. - P. 227.
91. Kauppinen K., Stubb S. Drug eruptions: causative agents and clinical types. A series of in-patients during a 10-year period // Acta Derm. Venereol. - 1984. - Vol. 64. - P. 320.
92. RoujeauJ.C., Stern R.S. Severe adverse cutaneous reactions to drugs//N. Engl. J. Med.- 1994. -Vol. 331.-P. 1272.
93. Levenson D.E. et al. Cutaneous manifestations of adverse drug reactions // Immunol. Allergy Clin. North Am. - 1991. - Vol. 11. - P. 493.
94. Alanko K. et al. Cutaneous drug reactions: clinical types and causative agents. A five-year survey of in-patients (1982-1985) // Acta Derm. Venereol. - 1989. - Vol. 69. - P. 223.
95. Hedner 71 et al. Angiooedema in relation to treatment with angiotensin converting enzyme inhibitors // Br. Med. J. - 1992. - Vol. 304. - P. 941.
96. Orfan N. et al. Severe angioedema related to ACE inhibitors in patients with a history of idiopathic angioedema // JAMA. - 1990. - Vol. 264. - P. 1287.
97. Chin H.L., Buchan D.A. Severe angioedema after long term use of an angiotensin-converting-enzyme inhibitor // Ann. Intern. Med. - 1990. - Vol. 112. - P. 312.
98. Anderson M.W., deShazo R.D. Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: the effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine and histamine // J. Allergy Clin. Immunol. - 1990. - Vol. 85. - P. 856.
